Johnson & Johnson is a global healthcare company that develops and manufactures a wide range of products across three major segments: Pharmaceuticals, Medical Devices, and Consumer Health. Its core products include prescription medications, surgical instruments, and consumer health products such as over-the-counter drugs and personal care items. The company generates revenue primarily from its pharmaceutical segment, which includes treatments for various diseases, followed by medical devices and consumer health products.
Johnson & Johnson presents a balanced investment profile, appealing to investors seeking a combination of growth and dividends. The company has a stable dividend yield, indicating a commitment to returning value to shareholders. Its diversified business segments provide resilience against market fluctuations, making it suitable for medium to long-term investment horizons.
| Data | Prima | Dopo | Motivo |
|---|---|---|---|
| 2026-06-10 00:46 | Mantieni | Compra | Strong momentum and solid dividend yield support growth. |
| 2026-05-30 02:42 | Compra | Mantieni | Weak momentum and fundamentals raise uncertainty. |
| 2026-05-22 02:50 | Mantieni | Compra | Stable dividends, but mixed momentum signals present uncertainty. |
| Data | Analista | Action | Target | Prezzo allora |
|---|---|---|---|---|
| 2026-05-13 10:04 | Leerink Partners | Rating migliorato | — → 265 | 224.26 |
| 2026-04-20 12:24 | Guggenheim | Target alzato | 244 → 266 | 232.71 |
| 2026-04-15 12:31 | Morgan Stanley | Target alzato | 267 → 283 | 239.66 |
